Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Reteplase, trade names include Retavase, is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them.
The analysis highlights Art and Overview as prominent areas in the source structure around Reteplase.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Reteplase shows recurring relationship patterns in the source. For example, Reteplase → Monograph Another extracted example is Reteplase → B01AD07 (WHO). Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
clots alteplase recombinant human tissue plasminogen activator penetrate trade names retavase protein bacterium half-life fibrin include thrombolytic drug used treat
TTTA extracted 12 structured relationships around Reteplase. Examples in this analysis include Reteplase → AHFS/Drugs.com → Monograph and Reteplase → ATC code → B01AD07 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Reteplase | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Reteplase | ATC code | B01AD07 (WHO) | 1.00 | infobox |
| Reteplase | CAS Number | 133652-38-7 Y | 1.00 | infobox |
| Reteplase | ChemSpider | none | 1.00 | infobox |
| Reteplase | DrugBank | DB00015 Y | 1.00 | infobox |
| Reteplase | Formula | C1736H2671N499O522S22 | 1.00 | infobox |
| Reteplase | KEGG | D05721 Y | 1.00 | infobox |
| Reteplase | License data | EU EMA: by INN | 1.00 | infobox |
| Reteplase | Molar mass | 39589.75 g·mol−1 | 1.00 | infobox |
| Reteplase | Trade names | Retavase, Retefuse, Rapilysin, Mirel, others | 1.00 | infobox |
| Reteplase | UNII | DQA630RIE9 | 1.00 | infobox |
| Reteplase | is a | recombinant non-glycosylated form of human tissue plasminogen activator | 0.90 | text |
The concept neighborhoods around Reteplase bring nearby vocabulary together. In this analysis, examples include Activator, Alteplase and Clots. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Bridges highlight paths between different parts of the Reteplase map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Reteplase to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Art & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Reteplase · EN edition · Analysis: TopicsToTalkAbout
